Gastroenterology
-
Gene role in stomach ulcers investigated
Genetics plays a part in peptic ulcer disease – but does not fully explain geographic variations in the disease, according to a major new study. Read more
-
Reflux disease not associated with increased cancer risk
Most people who have reflux disease do not have an increased risk of cancer, a new Swedish study has shown. Read more
-
Turmeric compound has potential for indigestion treatment
A natural compound found in turmeric may be as effective as omeprazole for treating indigestion symptoms, a Thai study published today has claimed. Read more
-
Gut conditions could be warning for Parkinson’s disease
Some gut problems, such as constipation, difficulty swallowing and irritable bowel syndrome, could be early warning signs of Parkinson’s disease, according to new studies. Read more
-
Novel antibody for rheumatoid arthritis and inflammatory bowel disease
A novel antibody has shown promise for conditions such as rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), researchers reported today. Read more
-
Evolution of part of E.coli capsule mapped for the first time
The evolutionary timeline and population distribution of Escherichia coli’s protective outer capsule has been mapped for the first time – and it shows how targeting the bacterium’s protective layer can help treat extraintestinal infections. Read more
-
Gene test could predict bowel cancer therapy success
A gene test already used by the NHS could help to predict if late-stage bowel cancer patients will benefit from chemotherapy. Read more
-
Chemotherapy first approach reduces risk of colon cancer return
Chemotherapy before surgery reduces the risk of colon cancer returning in two years by 28%, according to a new study. Read more
-
Which fatal condition stopped Edward the Black Prince in his prime?
Inflammatory bowel disease may have changed the course of English history, ending the life of a key member of the Plantagenet dynasty, an army doctor suggests today. Read more
-
Scientists tackle disease resistance to new cancer drug
British cancer researchers believe they might be able to ensure a “promising” new stomach cancer drug class is used in a way that outsmarts the disease’s ability to develop resistance. Read more